With incoming president Donald Trump threatening a trade war with China, experts told BioSpace that the new administration ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Gilead abandoned testing of the antibody in ... the drug is still in clinical development in China. Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar ...

Gilead has won another victory in a wide-ranging ... fallen more than 8% on speculation about an anti-corruption probe in China, its second-largest market, wiping around $14 billion off its ...

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of ...